These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 39265601

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The full value of immunisation against respiratory syncytial virus for infants younger than 1 year: effects beyond prevention of acute respiratory illness.
    Feikin DR, Karron RA, Saha SK, Sparrow E, Srikantiah P, Weinberger DM, Zar HJ.
    Lancet Infect Dis; 2024 May; 24(5):e318-e327. PubMed ID: 38000374
    [Abstract] [Full Text] [Related]

  • 3. Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies.
    Mazur NI, Caballero MT, Nunes MC.
    Lancet; 2024 Sep 21; 404(10458):1143-1156. PubMed ID: 39265587
    [Abstract] [Full Text] [Related]

  • 4. Early-life respiratory syncytial virus lower respiratory tract infection in a South African birth cohort: epidemiology and effect on lung health.
    Zar HJ, Nduru P, Stadler JAM, Gray D, Barnett W, Lesosky M, Myer L, Nicol MP.
    Lancet Glob Health; 2020 Oct 21; 8(10):e1316-e1325. PubMed ID: 32971054
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Determining the outcomes of interventions to prevent respiratory syncytial virus disease in children: what to measure?
    Karron RA, Zar HJ.
    Lancet Respir Med; 2018 Jan 21; 6(1):65-74. PubMed ID: 28865676
    [Abstract] [Full Text] [Related]

  • 8. Age-specific incidence rates and risk factors for respiratory syncytial virus-associated lower respiratory tract illness in cohort children under 5 years old in the Philippines.
    Ueno F, Tamaki R, Saito M, Okamoto M, Saito-Obata M, Kamigaki T, Suzuki A, Segubre-Mercado E, Aloyon HD, Tallo V, Lupisan SP, Oshitani H, RSV Working Group in the Philippines.
    Influenza Other Respir Viruses; 2019 Jul 21; 13(4):339-353. PubMed ID: 30891896
    [Abstract] [Full Text] [Related]

  • 9. Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting.
    Driscoll AJ, Arshad SH, Bont L, Brunwasser SM, Cherian T, Englund JA, Fell DB, Hammitt LL, Hartert TV, Innis BL, Karron RA, Langley GE, Mulholland EK, Munywoki PK, Nair H, Ortiz JR, Savitz DA, Scheltema NM, Simões EAF, Smith PG, Were F, Zar HJ, Feikin DR.
    Vaccine; 2020 Mar 04; 38(11):2435-2448. PubMed ID: 31974017
    [Abstract] [Full Text] [Related]

  • 10. Factors associated with severe respiratory syncytial virus infection among hospitalized children in Thammasat University Hospital.
    Bunjoungmanee P, Sompoch S, Tangsathapornpong A, Kulalert P.
    F1000Res; 2024 Mar 04; 13():231. PubMed ID: 39055881
    [Abstract] [Full Text] [Related]

  • 11. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
    Fleming-Dutra KE, Jones JM, Roper LE, Prill MM, Ortega-Sanchez IR, Moulia DL, Wallace M, Godfrey M, Broder KR, Tepper NK, Brooks O, Sánchez PJ, Kotton CN, Mahon BE, Long SS, McMorrow ML.
    MMWR Morb Mortal Wkly Rep; 2023 Oct 13; 72(41):1115-1122. PubMed ID: 37824423
    [Abstract] [Full Text] [Related]

  • 12. Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya.
    Nokes DJ, Okiro EA, Ngama M, Ochola R, White LJ, Scott PD, English M, Cane PA, Medley GF.
    Clin Infect Dis; 2008 Jan 01; 46(1):50-7. PubMed ID: 18171213
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study.
    Ares-Gómez S, Mallah N, Santiago-Pérez MI, Pardo-Seco J, Pérez-Martínez O, Otero-Barrós MT, Suárez-Gaiche N, Kramer R, Jin J, Platero-Alonso L, Alvárez-Gil RM, Ces-Ozores OM, Nartallo-Penas V, Mirás-Carballal S, Piñeiro-Sotelo M, Malvar-Pintos A, González-Pérez JM, Rodríguez-Tenreiro-Sánchez C, Rivero-Calle I, Salas A, Durán-Parrondo C, Martinón-Torres F, NIRSE-GAL study group.
    Lancet Infect Dis; 2024 Aug 01; 24(8):817-828. PubMed ID: 38701823
    [Abstract] [Full Text] [Related]

  • 14. The clinical impact of multiple prevention strategies for respiratory syncytial virus infections in infants and high-risk toddlers in the United States.
    Ektare V, Lang J, Choi Y, Finelli L.
    Vaccine; 2022 Oct 06; 40(42):6064-6073. PubMed ID: 36096968
    [Abstract] [Full Text] [Related]

  • 15. A Retrospective Cohort Study on Infant Respiratory Tract Infection Hospitalizations and Recurrent Wheeze and Asthma Risk: Impact of Respiratory Syncytial Virus.
    van Wijhe M, Johannesen CK, Simonsen L, Jørgensen IM, RESCEU Investigators, Fischer TK.
    J Infect Dis; 2022 Aug 12; 226(Suppl 1):S55-S62. PubMed ID: 35426942
    [Abstract] [Full Text] [Related]

  • 16. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.
    Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, Madhi SA, Omer SB, Simões EAF, Campbell H, Pariente AB, Bardach D, Bassat Q, Casalegno JS, Chakhunashvili G, Crawford N, Danilenko D, Do LAH, Echavarria M, Gentile A, Gordon A, Heikkinen T, Huang QS, Jullien S, Krishnan A, Lopez EL, Markić J, Mira-Iglesias A, Moore HC, Moyes J, Mwananyanda L, Nokes DJ, Noordeen F, Obodai E, Palani N, Romero C, Salimi V, Satav A, Seo E, Shchomak Z, Singleton R, Stolyarov K, Stoszek SK, von Gottberg A, Wurzel D, Yoshida LM, Yung CF, Zar HJ, Respiratory Virus Global Epidemiology Network, Nair H, RESCEU investigators.
    Lancet; 2022 May 28; 399(10340):2047-2064. PubMed ID: 35598608
    [Abstract] [Full Text] [Related]

  • 17. Respiratory Syncytial Virus-Associated Respiratory Diseases in Children and Adults.
    Tenenbaum T, Liese J, Welte T, Rademacher J.
    Dtsch Arztebl Int; 2024 May 03; 121(9):303-312. PubMed ID: 38652840
    [Abstract] [Full Text] [Related]

  • 18. Risk factors for the development of severe or very severe respiratory syncytial virus-related lower respiratory tract infection in Indian infants: A cohort study in Melghat, India.
    Crow R, Satav A, Potdar V, Satav S, Dani V, Simões EAF.
    Trop Med Int Health; 2024 Jul 03; 29(7):612-621. PubMed ID: 38741367
    [Abstract] [Full Text] [Related]

  • 19. The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist/immunologist.
    Frenkel LD, Gaur S, Bellanti JA.
    Allergy Asthma Proc; 2023 Jul 26; 44(4):220-228. PubMed ID: 37236777
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.